1Akers Jr DL, Fowl RJ, Kempczinski RF. Mycotic aneurysm of the tibioperoneal trunk:case report and review of the literature. J Vasc Surg,1992, 16:71-74.
2Brown SL, Busutill RW, Baker JD, et al.Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg,1984,1:541-547.
3Reddy DJ, Shepard AD, Evans JR, et al. Management of infected aortoilliac aneurysms.Arch Surg, 1991,126:873-878.
4Muller BT, Wegener OR, Grabitz K, et al.Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg, 2001,33:106-113.
5Oderich GS, Panneton JM, Bower TC, et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg, 2001,34:900-908.
6Yasuhara H, Muto T. Infected abdominal aortic aneurysm presenting with sudden appearance: diagnostic importance of serial computed tomography. Ann Vasc Surg, 2001,15:582-585.
7Gupta AK, Bandyk DF, Johnson BL. In situ repair of mycotic abdominal aortic aneurysms with rifampin-bonded gelatin-impregnated Dacron grafts: a preliminary case report. J Vasc Surg, 1996,24:472-476.
8Koshiko S, Sasajima T, Muraki S ,et al.Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg, 2002,35:779-785.
9Noel AA, Gloviczki P, Cherry Jr KJ, et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg, 2002,35:847-852.
10Vogt PR, Brunner-LaRocca HP, Lachat M, et al. Technical details with the use of cryopreserved arterial allografts for aortic infection: Influence on early and midterm mortality. J Vasc Surg, 2002,35:80-86.
